Continue Reading Cumulative Total Shareholder Returns of MediPharm Labs, Leading Canadian Cannabis Companies and Global X Marijuana Life Sciences Index (CNW Group/MediPharm Labs Corp.) MediPharm's Board of Directors (the "Board") recommends that shareholders vote through the GREEN proxy or GREEN voting instruction card in support of the Company's nominees for Board of Directors and other resolutions. Shareholders are encouraged to visit www.medipharmlabsagm.com for up-to-date information on matters relatin ...

Core Insights - Philip Morris is targeting a 13% to 15% growth in EPS for the year, reaffirming its guidance in a recent press release [2] - The company has been undergoing a smoke-free transformation for over 10 years, achieving its strongest growth since 2011, excluding the post-pandemic recovery [2] - Despite focusing on smoke-free products, the company is still seeing positive volume growth across its total business [3] Company Strategy - The emphasis is on transitioning from combustible products to smoke-free alternatives, including heat-not-burn and vaping products [3] - The company is committed to maintaining pressure on its combustible business while promoting smoke-free innovations [3]